Transfusion in the Patient With Sickle Cell Disease: A Critical Review of the Literature and Transfusion Guidelines

Transfusion Medicine Reviews

Volumn 21, Issue 2, 2007, Pages 118-133

  Josephson, Cassandra D ^a,b   Su, Leon L ^a,b   Hillyer, Krista L ^a,b   Hillyer, Christopher D ^a,b  

^a Laboratory Medicine   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIGEN; LEUKOCYTE ANTIGEN;

ACUTE CHEST SYNDROME; ACUTE HEPATIC SEQUESTRATION; ACUTE SPLENIC SEQUESTRATION; ACUTE SYMPTOMATIC ANEMIA; ALLOIMMUNIZATION; ANEMIA; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNITY; BLOOD TRANSFUSION REACTION; COR PULMONALE; ERYTHROCYTE TRANSFUSION; EYE SURGERY; GENERAL ANESTHESIA; HUMAN; INFECTION; INFECTION RISK; IRON OVERLOAD; KIDNEY FAILURE; LEG ULCER; LIVER DISEASE; MULTIPLE ORGAN FAILURE; PAIN; PREGNANCY; PREOPERATIVE CARE; PRIAPISM; PULMONARY HYPERTENSION; RECURRENT DISEASE; SICKLE CELL ANEMIA; SPLEEN DISEASE; STROKE;

ANEMIA, SICKLE CELL; BLOOD COMPONENT TRANSFUSION; GUIDELINES; HUMANS;

EID: 33947600686     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2006.11.003     Document Type: Article

References (50)

1. Platt O., Brambilla D., Rosse W., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330 (1994) 1639-1644
2. Reed W., and Vichinsky E. New considerations in the treatment of sickle cell disease. Annu Rev Med 49 (1998) 461-474
3. Nifong T., and Domen R. Oxygen saturation and hemoglobin A content in patients with sickle cell disease undergoing erythrocytapheresis. Ther Apher 6 (2002) 390-393
4. Thurston G., Henderson N., and Jeng M. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood. Clin Hemorheol Microcirc 30 (2004) 83-97
5. Afenyi-Annan A., and Brecher M. Pre-transfusion phenotype matching for sickle cell disease patients. Transfusion 44 (2004) 619-620 (letter)
6. Osby M., and Shulman I. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: A survey of 1182 North American laboratories. Arch Pathol Lab Med 129 (2005) 190-193
7. The management of sickle cell disease (ed 4). Bethesda, NIH Publication 02-2117, 2002, pp 153-160.
8. Emond A., Collis R., Darvill D., et al. Acute splenic sequestration in homozygous sickle cell disease: Natural history and management. J Pediatr 127 (1985) 201-206
9. Ohene-Frempong K., Weiner S., Sleeper L., et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 91 (1998) 288-294
10. Adams R., McKie V., Brambilla D., et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials 19 (1998) 110-129
11. Fullerton H., Adams R., Zhao S., et al. Declining stroke rates in Californian children with sickle cell disease. Blood 104 (2004) 336-339
12. Russell M., Goldberg H., Reis L., et al. Transfusion therapy for cerebrovascular abnormalities in sickle cell disease. JAMA 242 (1979) 2317-2318
13. Adams R. Hemoglobinopathies. Hematology (Am Soc Hematol Educ Program) (2003) 14-39
14. Davies S., Luce P., Win A., et al. Acute chest syndrome in sickle-cell disease. Lancet 1 (1984) 36-38
15. Quinn C., Rogers Z., and Buchanan G. Survival of children with sickle cell disease. Blood 103 (2004) 4023-4027
16. Mallouh A., and Asha M. Beneficial effect of blood transfusion on children with sickle cell chest syndrome. Am J Dis Child 142 (1988) 178-182
17. Miller S., and Rao S. Acute chest syndrome, transfusion, and neurologic events in children with sickle cell disease. Blood 102 (2003) 1556 (letter)
18. Henderson J., Noetzel M., McKinstry R., et al. Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood 101 (2003) 415-419
19. Hassell K., Eckman J., and Lane P. Acute multiorgan failure syndrome: A potentially catastrophic complication of severe sickle cell pain episodes. Am J Med 96 (1994) 155-162
20. Haberkern C., Neumayr L., Orringer E., et al. Cholecystectomy in sickle cell anemia patients: Perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Blood 89 (1997) 1543-1552
21. Vichinsky E., Haberken C., Neumayr L., et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 333 (1995) 206-213
22. Griffin T.C., and Buchanan G.R. Elective surgery in children with sickle cell disease without preoperative blood transfusion. J Pediatr Surg 28 (1993) 681-685
23. Hirst C., and Williamson L. Preoperative blood transfusions for sickle cell disease (Cochrane Review). The Cochrane Library, Issue 4 (2006), Wiley & Sons
24. Seargent G. Sickle cell disease. 2 ed. (1992), Oxford Medical publishers, Oxford 332
25. Powars D., Wilson B., Imbus C., et al. The natural history of stroke in sickle cell disease. Am J Med 65 (1978) 461-471
26. Peglow C., Adams R., Mckie V., et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusion. J Pediatr 126 (1995) 896-899
27. Cohen A., Martin M., Silber J., et al. A modified transfusion program for prevention of stroke in sickle cell disease. Blood 79 (1992) 1657-1661
28. Williams J., Goff J., Anderson H., et al. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr 96 (1980) 205-209
29. Wang W., Kovnar E., Tonkin I.L., et al. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 118 (1991) 377-382
30. Tuck S., James C., Brewster E., et al. Prophylactic blood transfusions in maternal sickle cell syndromes. Br J Obstet Gynecol 94 (1987) 121-125
31. Koshy M. Sickle cell disease and pregnancy. Blood Rev 9 (1995) 157-164
32. Simmons B., Santhanam V., Castaner A., et al. Sickle cell heart disease: Two dimensional echo and Doppler ultrasonographic findings in the heart of adult patients with sickle cell anemia. Arch Intern Med 148 (1988) 1526-1528
33. Sutton L., Castro O., Cross D., et al. Pulmonary hypertension in sickle cell disease. Am J Cardiol 74 (1994) 626-628
34. Hankins J., Jeng M., Harris S., et al. Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. J Pediatr Hematol Oncol 27 (2005) 158-161
35. Vichinsky E. Pulmonary hypertension in sickle cell disease. N Engl J Med 350 (2004) 857-859
36. Gladwin M., Sachdev V., Jison M., et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350 (2004) 886-895
37. Rifikind S., Waisman J., Thompson R., et al. RBC exchange pheresis for priapism in sickle cell disease. JAMA 242 (1979) 2317-2318
38. Miller S., Rao S., Dunn K., et al. Priapism in children with sickle cell disease. J Urol 154 (1995) 844-847
39. Platt O., Thorington B., Brambilla D., et al. Pain in sickle cell disease. N Engl J Med 325 (1991) 11-16
40. Schmalzer E., Lee J., Brown A., et al. Viscosity of mixtures of sickle cell and normal red cell at varying hematocrit levels. Transfusion 27 (1987) 228-233
41. Luban N., Strauss R., and Hume H. Commentary on the safety of red cells preserved in extended storage media for neonatal transfusions. Transfusion 31 (1991) 229-235
42. Vichinsky E., Earles A., Johnson R., et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 322 (1990) 1617-1621
43. Sosler S., Jilly B., Saporito C., et al. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Am J Hematol 43 (1993) 103-106
44. Ambruso D., Githens J., Alcorn R., et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 27 (1987) 94-98
45. Vichinsky E., Luban N., Wright E., et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: A multicenter transfusion trial. Transfusion 41 (2001) 1086-1092
46. Tahhan H., Holbrook C., Braddy L., et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 34 (1994) 562-569
47. Castro O., Sandier G., Houston-Yu P., et al. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: Theoretical and practical implications. Transfusion 42 (2002) 684-690
48. Castellino S., Combs M., Zimmerman S., et al. Erythrocyte autoantibodies in pediatric patients with sickle cell disease receiving transfusion therapy: Frequency, characteristics, and significance. Br J Haemotol 104 (1999) 189-194
49. Friedman D., Lukas M., Jawad A., et al. Alloimmunization to platelets in heavily transfused patients with sickle cell disease. Blood 88 (1996) 3216-3222
50. Hilliard L., Williams B., Lounsbury A., et al. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients. Am J Hematol 59 (1998) 28-35